As of October 27, 2026, CRISPR Therapeutics AG is a publicly traded company (Nasdaq: CRSP); its largest reported holder is ARK Invest, with 11.79% on Schedule 13G/A of April 30, 2026, then BlackRock (8.3%). The largest insider holding is Simeon George, a director, with 2,054,249 shares (2.1% of shares outstanding), per Form 4 of October 16, 2026 (Schedule 13G/A, April 30, 2026).
About to sign with, pay or invest in CRISPR Therapeutics AG? See the free Snapshot first.
Free to see. No signup.
Is CRISPR Therapeutics AG a real, registered company?
- CRISPR Therapeutics AG files with the SEC under CIK 1674416 (its SEC filings).
- Its shares are listed under the ticker CRSP on Nasdaq (SEC company record).
- Incorporated in V8, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under CRISPR Therapeutics AG in our court records and SEC 8-K records (as of 2026-10-27).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Orbis Investment Management Ltd. (filed 2026-08-14).
Who are CRISPR Therapeutics AG's owners and officers?
CRISPR Therapeutics AG: industry Biological Products, (No Diagnostic Substances) (Schedule 13G/A, 2026-08-14).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-08-14 | Orbis Investment Management LTD | 5.6% |
| Schedule 13G/A, 2026-07-27 | Blackrock, Inc. | 8.3% |
| Schedule 13G/A, 2026-05-15 | Orbis Investment Management LTD | 6.3% |
| Schedule 13G, 2026-05-14 | Capital World Investors | 5.1% |
| Schedule 13G/A, 2026-04-30 | Ark Investment Management LLC | 11.79% |
| Schedule 13G/A, 2026-02-17 | Orbis Investment Management LTD | 6.2% |
| Schedule 13G/A, 2026-02-05 | Capital International Investors | 1.2% |
| Schedule 13G, 2025-11-14 | Orbis Investment Management LTD | 5.5% |
| Schedule 13G/A, 2025-11-04 | Ark Investment Management LLC | 10.76% |
| Schedule 13G, 2025-07-17 | Blackrock, Inc. | 6.9% |
Want the whole picture on CRISPR Therapeutics AG?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on CRISPR Therapeutics AG: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on CRISPR Therapeutics AG covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
16 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Which insiders own CRISPR Therapeutics AG shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , a director: 2,054,249 shares (2.1% of shares outstanding), 15,486 held directly and 2,038,763 indirectly (Form 4, 2026-10-16).
- , the chief executive and a director: 311,899 shares (0.32% of shares outstanding) (Form 4, 2026-10-20).
- , the general counsel and secretary: 95,857 shares (0.10% of shares outstanding) (Form 4, 2026-10-15).
- , a director: 22,000 shares (0.02% of shares outstanding) (Form 4, 2025-08-08).
- , the chief medical officer: 19,357 shares (0.02% of shares outstanding) (Form 4, 2026-06-01).
Shares outstanding: 96,692,653 as of 2026-07-31, from the company's latest SEC cover page.
How much has CRISPR Therapeutics AG raised?
No fundraising or offering filing from CRISPR Therapeutics AG is on file with us.
Keep reading
More on CRISPR Therapeutics AG and the records around it.
CRISPR Therapeutics AG elsewhere on the record
- 5%+ stake filings Aug 2026
Companies that share a holder
- ARK Investment Management LLC also filed stake reports on 20 other companies: 10x Genomics, Inc. (Oct 2026), Twist Bioscience Corp (Sep 2026), 908 Devices Inc. (Aug 2026)
- ORBIS INVESTMENT MANAGEMENT LTD also filed stake reports on 23 other companies: National CineMedia, Inc. (Sep 2026), BBB FOODS INC (Aug 2026), Burford Capital Ltd (Aug 2026)
- Capital International Investors also filed stake reports on 95 other companies: Arxis, Inc. (Aug 2026), Astronics Corp. (Aug 2026), BBB Foods Inc. (Aug 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/crispr-therapeutics-ag